LOXL4 and cancer: Interestingly, the staining levels of COL1A1, a significant component of cancer-associated collagens, and CD31, a representative endothelial cell marker, were reduced substantially in the LOXL4 KO cell-derived tumors and the LOXL4 mutCA subline-derived tumors (Figures 2C, D).